Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 4 | Unknown | — |
The patient took dose of Vivotif immediately after eating dinner, previously patient took three doses, all of them immediately after eating; Case reference number US-BN-2025-000270 is a spontaneous case initially received from a pharmacist via Communication (reference number: USBAV25-0391) on 20-Feb-2025 and concerns a male patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On unspecified date, the patient took dose of Vivotif immediately after eating dinner (batch number: unknown), at unknown dose, route or site of administration for unknown indication, The patient previously also taken three doses immediately after eating. (explicitly coded as 'Drug administration error'). At the time of the initial report, it was unknown if the patient experienced any of adverse events due Vivotif. No further information was provided.; Reporter's Comments: A male patient of unspecified age took dose of Vivotif immediately after eating dinner, at unknown dose, route or site of administration for unknown indication, The patient previously also taken three doses immediately after eating which is considered as drug administration error. Product administration error is considered listed per company convention. At this point, it was unknown if the patient experienced any of adverse events due Vivotif. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A male patient of unspecified age took dose of Vivotif immediately after eating dinner, at unknown dose, route or site of administration for unknown indication, The patient previously also taken three doses immediately after eating which is considered as drug administration error. Product administration error is considered listed per company convention. At this point, it was unknown if the patient experienced any of adverse events due Vivotif. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.
Comments: None